Over the past year, in recognition of their research and dedication to treating patients with cancer, several physician-scientists from City of Hope received awards, fellowships, and honor society inductions. These recipients listed below are experts in a variety of cancers and treatments, ranging from gastrointestinal and hematologic malignancies to immunotherapies and gene therapies.
Yuman Fong, MD
Yuman Fong, MD, was inducted into the American Institute for Medical and Biological Engineering College of Fellows in March. He is an internationally recognized expert in cancers of the liver, pancreas, gallbladder, and bile ducts and has pioneered many surgical, laparoscopic, robotic, and ablative therapies for hepatobiliary cancers.Dr. Fong has led research to employ genetically engineered viruses to kill cancer cells and was one of the first scientists to administer engineered viruses into the human bloodstream to treat cancer.
Markus Müschen, MD, PhD, is among 80 physician-scientists who were admitted into The American Society for Clinical Investigation this year. Dr. Müschen, Professor and Chair of the Department of Systems Biology at City of Hope, and his colleagues have developed a comprehensive research program that will predict relapse of acute lymphoblastic leukemia (ALL) and a drug-discovery program that will help to prevent or overcome ALL relapse in children.
Steven Rosen, MD, Provost and Chief Scientific Officer at City of Hope, was admitted into the Association of American Physicians in April. Together with Christiane Querfeld, MD, PhD, Dr. Rosen recently received $7.5 million to -develop treatment for cutaneous T-cell lymphoma.
John Rossi, PhD, Chair of the Department of Molecular and Cellular Biology at City of Hope, was given the Outstanding Achievement Award, the highest honor given by the American Society of Gene & Cell Therapy. Dr. Rossi is a pioneer in creating highly structured RNA aptamers that deliver RNA into HIV-infected cells to provide a type of gene therapy for HIV and cancer.
Brandon Tan, PhD, a postdoctoral fellow in the Department of Systems Biology at City of Hope, received the American Association for Cancer Research Breast Cancer Research Fellowship in March. The 2-year, $120,000 grant funds basic, translational, clinical, or epidemiologic research that has direct applicability and relevance to breast cancer.
Michael Caligiuri, MD, President of City of Hope National Medical Center, received the Janeway Medal from the American Radium Society in 2019 for his scientific contributions in the field of immunology, lymphoma, and leukemia. ■
